Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.00650-26 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Kai-Su Pan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Antifungal Agents, Talaromyces. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
This study aimed to establish epidemiological cutoff values (ECVs) for amphotericin B, fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against Talaromyces marneffei ( T. marneffei ) using the CLSI broth microdilution method. Antifungal susceptibility testing of 207 T. marneffei isolates was performed independently at five laboratories across China according to CLSI M27-A4 guidelines. Minimum inhibitory concentration (MIC) distributions were analyzed using ECOFFinder software (version 2.1), and ECVs were set at the upper MIC limit encompassing 97.5% of the modeled wild-type (WT) population. ECVs were determined as follows: amphotericin B (AMB) 8 µg/mL, voriconazole (VRC) 0.03 µg/mL, itraconazole (ITC) 0.125 µg/mL, posaconazole (POS) 0.06 µg/mL, isavuconazole (ISA) 0.125 µg/mL, and fluconazole (FLC) 8 µg/mL. MIC distributions for all six agents conformed well to the fitted models (normal or log-normal), supporting the validity of ECV determination. No non-WT isolates were detected for amphotericin B, whereas non-WT rates for azoles were 15.5% (voriconazole), 8.45% (itraconazole), 6.37% (posaconazole), 3.0% (fluconazole), and 1.02% (isavuconazole). Among voriconazole non-WT isolates, all were from patients with prior voriconazole exposure. This study provides the first standardized ECVs for T. marneffei against six key antifungal agents. The data establish a reference framework for antifungal susceptibility testing and resistance surveillance and highlight the need for continued monitoring of azole susceptibility in this pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Guangxi Scientific and Technological Innovation Cooperation Base of Mycosis Prevention and Control, Nanning, China.
- Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
- Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Medical Mycology, Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
- Department of Dermatology and Venereology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Kai-Su Pan, Ying-Gai Song, Xiao-Fang Li, Hai-Lin Zheng, Yanqing Zheng, Li-Yan Xi, He-Ping Xu, Paul E Verweij, Cun-Wei Cao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Pan, K., Song, Y., Lu, S., Li, X., Huang, H., Gong, J., Li, R., Zheng, H., Zhan, M., Zhang, S., Zhou, X., Geng, Y., Jiang, S., Fang, S., Zheng, Y., Zheng, D., Wu, W., Xi, L., Xu, H., …, & Cao, C. (2026). Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00650-26
Vancouver
Pan K, Song Y, Lu S, Li X, Huang H, Gong J, et al. Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00650-26
BibTeX
@article{Pan2026,
author = {Pan, Kai-Su and Song, Ying-Gai and Lu, Sha and Li, Xiao-Fang and Huang, Huai-Qiu and Gong, Jie and Li, Ruo-Yu and Zheng, Hai-Lin and Zhan, Miao-Rong and Zhang, Shu and Zhou, Xin-Yu and Geng, Yuan-Yuan and Jiang, Si-Wen and Fang, Sheng-Xiu and Zheng, Yanqing and Zheng, Dong-Yan and Wu, Weixuan and Xi, Li-Yan and Xu, He-Ping and Verweij, Paul E and Cao, Cun-Wei},
title = {Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00650-26}
}
EUVIMED